Zenara Pharma Receives Nod To Sell Covid-19 Drug Favipiravir

Zenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, has received an approval from the Drugs Controller General of India (DCGI) to manufacture and sell Favipiravir tablets for treating patients with mild to moderate symptoms of Covid-19. The tablet, to be sold under the brand name 'Favizen', will be manufactured at Zenara's US FDA approved facility in Hyderabad.